Market Brief BoJos Brexit Breaks Through the EU
See a summary of the top market themes and trends from today's US trading session!
Share this:
- Brexit headlines once again flew hot and heavy today, with the UK government and the EU reaching an agreement, though the prospect of Parliamentary approval this weekend looks tenuous with the DUP vowing to vote against the deal (see more here and here).
- Turkish President Erdogan and US VP Pence reportedly reached an agreement to suspend Turkey’s assault on Syria. The Turkish lira gained ground against the US dollar for the third straight day.
- FX: The aussie and the kiwi were the strongest major currencies on the day, while the US dollar was the day’s weakest major currency.
- US data: Industrial Production (Sept) came in soft at -0.4% vs. -0.2% eyed, though last month’s reading was revised up by 0.2%. US Housing Starts (Sept) were also weaker than expected at just 1256K. Finally, the Philly Fed Manufacturing Survey came in at 5.6, below 7.3 eyed.
- Commodities: Both gold and oil traded higher on the day, with oil prices gaining 1% on a late rally to hit their highest levels of the week despite a larger-than-expected buildup of EIA inventories.
- US indices finished marginally higher on the day to close at a fresh 4-week high.
- Health care stocks (XLV) led the way higher, while Technology (XLK) was the laggard and the only sector to close lower on the day.
- Stocks on the move:
- After gapping more than 6% higher on yesterday’s earnings release, Netflix (NFLX) traded lower throughout the day, ultimately closing 3% higher on the day.
- JP Morgan (JPM, +1%) probed its record high near 122.00 intraday after CEO Jamie Dimon delivered another strong quarterly earnings report.
- IBM (IBM) dumped -6% after seeing revenue fall for the fifth consecutive quarter. Recently acquired Red Hat grew revenue 19% in the quarter.
- Marijuana company Cronos (CRON) gapped 25% higher on news that its partially owned Australian subsidiary would IPO next month, but the stock ultimately closed just 5% higher on the day.
- Recent IPO Beyond Meat (BYND) fell -4% today and is now down more than 50% from July’s record high.
- Brexit headlines once again flew hot and heavy today, with the UK government and the EU reaching an agreement, though the prospect of Parliamentary approval this weekend looks tenuous with the DUP vowing to vote against the deal (see more here and here).
- Turkish President Erdogan and US VP Pence reportedly reached an agreement to suspend Turkey’s assault on Syria. The Turkish lira gained ground against the US dollar for the third straight day.
- FX: The aussie and the kiwi were the strongest major currencies on the day, while the US dollar was the day’s weakest major currency.
- US data: Industrial Production (Sept) came in soft at -0.4% vs. -0.2% eyed, though last month’s reading was revised up by 0.2%. US Housing Starts (Sept) were also weaker than expected at just 1256K. Finally, the Philly Fed Manufacturing Survey came in at 5.6, below 7.3 eyed.
- Commodities: Both gold and oil traded higher on the day, with oil prices gaining 1% on a late rally to hit their highest levels of the week despite a larger-than-expected buildup of EIA inventories.
- US indices finished marginally higher on the day to close at a fresh 4-week high.
- Health care stocks (XLV) led the way higher, while Technology (XLK) was the laggard and the only sector to close lower on the day.
- Stocks on the move:
- After gapping more than 6% higher on yesterday’s earnings release, Netflix (NFLX) traded lower throughout the day, ultimately closing 3% higher on the day.
- JP Morgan (JPM, +1%) probed its record high near 122.00 intraday after CEO Jamie Dimon delivered another strong quarterly earnings report.
- IBM (IBM) dumped -6% after seeing revenue fall for the fifth consecutive quarter. Recently acquired Red Hat grew revenue 19% in the quarter.
- Marijuana company Cronos (CRON) gapped 25% higher on news that its partially owned Australian subsidiary would IPO next month, but the stock ultimately closed just 5% higher on the day.
- Recent IPO Beyond Meat (BYND) fell -4% today and is now down more than 50% from July’s record high.
Latest market news
The complete CFD trading experience
Award-winning platforms, competitive spreads, low commissions and dedicated support.
We live and breathe the markets and are dedicated to helping traders realise their ambitions as we continue to set the industry bar.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.
Related articles
Canadian Dollar Analysis: USD/CAD Returns to July Highs Ahead of NFP
The Canadian dollar continues to face one of its most challenging environments in recent months when it comes to maintaining strength against the U.S. dollar. The weakness of the Canadian currency is clearly reflected in USD/CAD, which has now recorded nine consecutive bullish sessions and gained more than 1.7% during that period.
US Dollar Technical Outlook: DXY Bulls Meet Resistance at Yearly Highs 10 1 2026
The U.S. Dollar has held firm despite fading Fed hike bets, but Friday’s payrolls could test the rally’s staying power.
Dow Jones forecast: Stock markets under pressure from multiple sources
When looking at the major tech-heavy US indices like the S&P 500 or the Nasdaq 100, you wouldn’t think that the stock market is particularly weak. Yet, beneath the surface, the market is far from healthy right now. Investors are evidently just piling into the big tech and AI names, and as a result, market breadth is deteriorating. Other indices like the small cap Russell 2000 and the Dow Jones are starting to reflect that weakness.
StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.
StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.